4,159 Shares in Sanofi (NASDAQ:SNY) Acquired by Clifford Capital Partners LLC

Clifford Capital Partners LLC acquired a new position in shares of Sanofi (NASDAQ:SNY) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,159 shares of the company’s stock, valued at approximately $202,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SNY. Scotia Capital Inc. grew its holdings in shares of Sanofi by 186.8% during the fourth quarter. Scotia Capital Inc. now owns 13,411 shares of the company’s stock worth $667,000 after purchasing an additional 8,735 shares during the last quarter. Jones Financial Companies Lllp increased its position in Sanofi by 197.5% in the 4th quarter. Jones Financial Companies Lllp now owns 1,050 shares of the company’s stock valued at $52,000 after acquiring an additional 697 shares during the period. Peapack Gladstone Financial Corp lifted its holdings in shares of Sanofi by 63.0% during the fourth quarter. Peapack Gladstone Financial Corp now owns 27,524 shares of the company’s stock worth $1,369,000 after purchasing an additional 10,641 shares during the period. First Trust Advisors LP increased its holdings in Sanofi by 10.3% in the fourth quarter. First Trust Advisors LP now owns 1,355,033 shares of the company’s stock valued at $67,386,000 after purchasing an additional 127,006 shares during the period. Finally, Lake Street Advisors Group LLC acquired a new position in Sanofi during the 4th quarter worth about $286,000. 10.04% of the stock is currently owned by institutional investors.

Sanofi Stock Performance

Shares of Sanofi stock opened at $57.31 on Wednesday. The business has a 50-day simple moving average of $55.31 and a 200 day simple moving average of $50.97. The firm has a market capitalization of $145.43 billion, a price-to-earnings ratio of 28.80, a PEG ratio of 1.62 and a beta of 0.60. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.00 and a quick ratio of 0.65. Sanofi has a one year low of $42.63 and a one year high of $58.97.

Sanofi (NASDAQ:SNY) last issued its earnings results on Thursday, July 25th. The company reported $0.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.88 by $0.05. The company had revenue of $10.75 billion for the quarter, compared to analysts’ expectations of $16.86 billion. Sanofi had a return on equity of 26.29% and a net margin of 9.60%. Sanofi’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period last year, the business earned $0.95 EPS. On average, research analysts anticipate that Sanofi will post 4.26 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on SNY. Argus boosted their price target on shares of Sanofi from $55.00 to $60.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. StockNews.com raised shares of Sanofi from a “buy” rating to a “strong-buy” rating in a research report on Wednesday. Finally, Citigroup raised Sanofi to a “strong-buy” rating in a research note on Tuesday, September 17th. Three research analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $57.50.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.